HEMABATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hemabate, and what generic alternatives are available?
Hemabate is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in HEMABATE is carboprost tromethamine. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the carboprost tromethamine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hemabate
A generic version of HEMABATE was approved as carboprost tromethamine by DR REDDYS on July 2nd, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HEMABATE?
- What are the global sales for HEMABATE?
- What is Average Wholesale Price for HEMABATE?
Summary for HEMABATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 40 |
Clinical Trials: | 6 |
Patent Applications: | 228 |
Drug Prices: | Drug price information for HEMABATE |
What excipients (inactive ingredients) are in HEMABATE? | HEMABATE excipients list |
DailyMed Link: | HEMABATE at DailyMed |
Recent Clinical Trials for HEMABATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Northwestern University | Early Phase 1 |
West China Second University Hospital | Phase 4 |
Dongguan Maternity & Child Health Hospital | N/A |
Pharmacology for HEMABATE
Drug Class | Prostaglandin Analog |
US Patents and Regulatory Information for HEMABATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | HEMABATE | carboprost tromethamine | INJECTABLE;INJECTION | 017989-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for HEMABATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | HEMABATE | carboprost tromethamine | INJECTABLE;INJECTION | 017989-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for HEMABATE
See the table below for patents covering HEMABATE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
U.S.S.R. | 416939 | ⤷ Sign Up | |
United Kingdom | 1314291 | ⤷ Sign Up | |
Spain | 390709 | ⤷ Sign Up | |
Poland | 81615 | ⤷ Sign Up | |
Norway | 135935 | ⤷ Sign Up | |
Finland | 57582 | ⤷ Sign Up | |
Argentina | 193032 | UN PROCEDIMIENTO PARA PRODUCIR DERIVADOS DEL ACIDO PROSTANOICO | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |